GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,007,870 | -15.0% | 2,316,372 | +1.9% | 0.38% | -12.0% |
| Q2 2023 | $135,345,435 | +28.2% | 2,273,185 | +22.0% | 0.43% | +17.9% |
| Q1 2023 | $105,537,992 | -38.7% | 1,863,312 | -19.6% | 0.37% | -44.2% |
| Q4 2022 | $172,141,892 | +63.5% | 2,317,785 | +31.2% | 0.66% | +58.4% |
| Q3 2022 | $105,276,000 | +8.1% | 1,767,258 | +1.9% | 0.42% | +15.2% |
| Q2 2022 | $97,391,000 | +262.1% | 1,734,795 | +375.9% | 0.36% | +351.2% |
| Q1 2022 | $26,895,000 | +17.3% | 364,524 | +14.7% | 0.08% | +29.0% |
| Q4 2021 | $22,937,000 | +79.2% | 317,684 | +90.2% | 0.06% | +72.2% |
| Q3 2021 | $12,801,000 | +0.2% | 167,067 | +1.4% | 0.04% | -10.0% |
| Q2 2021 | $12,771,000 | +32.7% | 164,719 | +5.6% | 0.04% | +29.0% |
| Q1 2021 | $9,622,000 | +3703.2% | 156,022 | +3014.2% | 0.03% | +3000.0% |
| Q2 2018 | $253,000 | – | 5,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |